← Open Payments lookup

GILBERT DANIEL: Open Payments

NPI 1467401182 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,176 in 48 payments from 16 companies in 2025. Trend: 2023 $1,885 · 2024 $2,068 · 2025 $1,176

Food & beverage: $1,176
CompanyPaymentsAmount
Alkermes, Inc.13$303
Otsuka America Pharmaceutical, Inc.10$222
Novo Nordisk Inc4$106
GlaxoSmithKline, LLC.3$84
Boehringer Ingelheim Pharmaceuticals, Inc.3$81
Amgen Inc.3$79
AstraZeneca Pharmaceuticals LP2$50
ViiV Healthcare Company2$48
Gilead Sciences, Inc.1$30
Lilly USA, LLC1$29

Products named: ARISTADA, REXULTI, JARDIANCE, OTEZLA, TRELEGY ELLIPTA, Wegovy, CABENUVA, AIRSUPRA.

Industry payments across DC — which companies pay providers there.